Oxaprozin
Active substance: oxaprozin
TABLET · OXAPROZIN 600 mg/1
United StatesActive
Marketing holder: Amneal Pharmaceuticals NY LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- OXAPROZIN · 600 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3872-7261-b6e4-8e8b9b0642b8,01a1208c-b62a-72ee-b5f5-d683848e8d1f,01a1208d-4201-7cb4-a777-2b8d226e713a,01a1208d-5d04-7458-b3bb-5e2567d33a1b,01a12092-7c78-78af-bc4b-5c752ef3b360;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 69238-1120
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 69238-1120 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69238-1120 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69238-1120 · Verified 2026-10-09 · open in source